CollPlant Biotechnologies Ltd - ADR
$0.36
$0.02
(4.86%)
As on 03-Sep-2026 12:35EDT
Market cap
$7 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.1
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-6
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1
-
Face value
--
-
Shares outstanding
18,908,207
10 Years Aggregate
CFO
$-42.58 Mln
EBITDA
$-53.78 Mln
Net Profit
$-71.54 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
CollPlant Biotechnologies - ADR
| -74.3 | 31.9 | -10.0 | -86.4 | -62.6 | -54.2 | -- |
|
BSE Sensex
| -10.1 | -2.5 | 2.0 | -5.0 | 5.2 | 5.7 | 10.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
CollPlant Biotechnologies - ADR
| -61.1 | -23.5 | -49.0 | 51.9 | 88.9 | 35.7 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
CollPlant Biotechnologies - ADR
|
0.4 | 6.8 | 0.4 | -13.1 | -3,318.3 | -185.1 | -- | 1.1 |
| 2.6 | 246.3 | 74.0 | 35.2 | 0.0 | 36.8 | 6.8 | 2.9 | |
| 0.5 | 8.7 | 1.3 | -9.1 | -1,029.8 | -- | -- | 6.2 | |
| 3.9 | 4.3 | 0.0 | -13.4 | -- | -90.4 | -- | 0.3 | |
| 70.7 | 225.3 | 1.8 | -16.3 | 0.0 | -46.1 | -- | 4.9 | |
| 45.1 | 2,132.2 | 188.7 | -97.6 | -38.6 | -- | -- | 19.3 |
Shareholding Pattern
View DetailsAbout CollPlant Biotechnologies - ADR
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products... are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound care product for the treatment of deep surgical incisions and deep wounds. It also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. The company has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel. Read more
-
CEO & Director
Mr. Yehiel Tal
-
CEO & Director
Mr. Yehiel Tal
-
Headquarters
Rehovot
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for CollPlant Biotechnologies - ADR
What is the current share price of CollPlant Biotechnologies Ltd - ADR Today?
The share price of CollPlant Biotechnologies Ltd - ADR is $0.36 (NASDAQ) as of 03-Sep-2026 12:35 EDT. CollPlant Biotechnologies Ltd - ADR has given a return of -62.58% in the last 3 years.
What is the current PB & PE ratio of CollPlant Biotechnologies Ltd - ADR?
Since, TTM earnings of CollPlant Biotechnologies Ltd - ADR is negative, P/E ratio is not available.
The P/B ratio of CollPlant Biotechnologies Ltd - ADR is 1.12 times as on 28-Aug-2026, a 77 discount to its peers’ median range of 4.94 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.56 |
2.95 |
2024 |
-2.48 |
3.06 |
2023 |
-10.43 |
2.58 |
2022 |
-5.52 |
2.89 |
2021 |
740.51 |
3.89 |
What is the 52 Week High and Low of CollPlant Biotechnologies Ltd - ADR?
The 52-week high and low of CollPlant Biotechnologies Ltd - ADR are Rs 3.18 and Rs 0.26 as of 03-Sep-2026.
What is the market cap of CollPlant Biotechnologies Ltd - ADR?
CollPlant Biotechnologies Ltd - ADR has a market capitalisation of $ 7 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in CollPlant Biotechnologies Ltd - ADR?
Before investing in CollPlant Biotechnologies Ltd - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.